Antibody-antigen complex formation with immobilized immunoglobulins

Area of Science:

• Biochemistry
• Immunology
• Assay Development

Background:

• Competitive immunoassays rely on the interaction between immobilized antibodies and labeled antigens (tracers).
• The size difference between analytes and tracers, antibody density, and immobilization method significantly influence assay performance.
• Understanding these factors is crucial for optimizing assay sensitivity and signal-to-noise ratio.

Purpose of the Study:

• To investigate the impact of antigen and tracer size on antibody-antigen complex formation in immobilized systems.
• To evaluate different antibody immobilization methods and their effect on competitive immunoassay performance.
• To develop a model for antibody immobilization that considers tracer size, complex formation, and antibody density for optimized immunoassay design.

Main Methods:

• Utilized an iodinated progesterone derivative and a progesterone-horseradish peroxidase conjugate as tracers with a monoclonal antibody.
• Immobilized the monoclonal antibody using physical adsorption, chemical binding, and protein G-mediated binding (with and without gelatin).
• Analyzed complex formation, antibody density, and binding constants to assess immunoassay performance.

Main Results:

• Antigen size significantly impacts maximal complex density, with smaller antigens forming higher densities.
• Tracer size has a lesser effect on dose-response curves compared to antibody binding constants.
• A large enzyme tracer with a low binding constant can enhance assay sensitivity; smaller tracers improve signal-to-noise ratio.

Conclusions:

• Immunoassay performance is a multifactorial outcome influenced by tracer-analyte size ratio, antibody density, immobilization technique, and binding affinities.
• A proposed model accounts for the interplay between tracer size, complex formation, and antibody density in immobilized systems.
• These findings facilitate the design and optimization of immunoassays, particularly for converting radioimmunoassays to enzyme immunoassays.